SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
Carcinoma, Non-Small-Cell-Lung, Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer
About this trial
This is an interventional health services research trial for Carcinoma, Non-Small-Cell-Lung
Eligibility Criteria
Inclusion Criteria:
- Newly diagnosed suspected or proven clinical stage I NSCLC (T1 or T2, N0, M0) with no prior treatment for this disease.
- At least 18 years of age.
- Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
Sites / Locations
- Washington University School of Medicine
Arms of the Study
Arm 1
Experimental
High-risk NSCLC participants
Baseline assessment of demographics and comorbidities Comorbidity scoring by interview and chart review: the Adult Comorbidity Evaluation 27, Charlson Comorbidity Index, Global Initiative for Chronic Obstructive Lung Disease, Cumulative Illness Rating Scale, and COMorbidities in Chronic Obstructive Lung Disease. Katz Activities of Daily Living: assessment of grip strength, walk speed, and activities of daily living HRQOL questionnaires will also be administered prior to treatment and then repeated throughout follow-up: the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) C30, EORTC QLQ-LC13, Modified Medical Research Council, EQ-5D, CES-D, and Medical Outcomes Study Social Support Survey. All questionnaire responses will be obtained with the use of a computer assisted interview system which can be used to collect data in person or through telephone interviews